Security record · archived quarter
RDNT
RadNet, Inc. · Healthcare · Medical - Diagnostics & Research
15Tracked holders
0Δ holders
23.28MShares held
$1.32BReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -0.9% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 23.94K | $1.64M | n/a | n/a |
| Q2 2026 | 104 | -5 | 51.24M | $3.16B | +4 | −8 |
| Q1 2026 | 111 | +1 | 48.78M | $2.73B | +12 | −12 |
| Q4 2025 | 110 | 0 | 52.41M | $3.74B | +2 | −1 |
| Q3 2025 | 17 | 0 | 26.52M | $2.02B | +1 | −2 |
| Q2 2025 | 15 | 0 | 23.28M | $1.32B | n/a | n/a |
| Q1 2025 | 12 | -1 | 6.79M | $337.54M | +1 | −2 |
| Q4 2024 | 13 | +1 | 7.21M | $503.69M | +1 | n/a |
| Q3 2024 | 11 | +1 | 5.72M | $396.88M | +2 | −1 |
| Q2 2024 | 10 | n/a | 4.46M | $262.91M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 9.30M | n/a | $529.05M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passive) | 7.39M | n/a | $420.50M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.48M | +0.1% | $141.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.64M | +2.3% | $93.35M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 545.61K | -3.9% | $31.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 524.16K | +41.9% | $29.83M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 7 | Adage Capital Partners ✦ | 403.15K | +142.1% | $22.94M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 376.19K | +179.8% | $21.41M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 329.61K | -59.5% | $18.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 146.60K | -31.0% | $8.34M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 58.24K | -28.0% | $3.31M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 45.68K | -75.0% | $2.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Marshall Wace ✦ | 20.01K | -88.3% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 12.00K | +75.3% | $683,148 | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 15 | Fidelity (FMR) ✦ | 6.54K | n/a | $372,284 | 0.0% | n/c | 1 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 337 holders, 76.63M shares, $3.90B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API